PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28558368-4	2017	METHODS: The mouse breast cancer cell line 4T1 was transfected with an inducible, bidirectional tetracycline (Bi-Tet) promoter driving VEGF and renilla luciferase (Rluc).	Tetracycline	96-108	vascular endothelial growth factor A	Mus musculus	135-139	
33394314-5	2021	By crossing with VegftetO/tetO mice, that has tetracycline operator sequences insertion in 5"-UTR region, it allows us to reversibly inhibit lung VEGF transcription from its endogenous level through doxycycline food, water or injection.	Tetracycline	46-58	vascular endothelial growth factor A	Mus musculus	146-150	
18154515-3	2007	Mouse embryonic stem (ES) cells were transfected with an inducible, bidirectional tetracycline (Bi-Tet) promoter driving VEGF(165) and renilla luciferase (Rluc).	Tetracycline	82-94	vascular endothelial growth factor A	Mus musculus	121-125	
10534339-5	1999	We previously reported that VEGF tightly regulated murine HCC development, based on the results of a study using a retroviral tetracycline-regulated (Retro-Tet) gene expression system.	Tetracycline	126-138	vascular endothelial growth factor A	Mus musculus	28-32	
10534339-6	1999	This system allows VEGF gene expression to be manipulated in vivo by providing tetracycline in the drinking water.	Tetracycline	79-91	vascular endothelial growth factor A	Mus musculus	19-23	
9828211-5	1998	We used a self-contained, tetracycline-regulated retroviral vector system to elucidate the effect of VEGF on murine HCC development in a xenograft experimental model.	Tetracycline	26-38	vascular endothelial growth factor A	Mus musculus	101-105	
9828211-6	1998	By delivering the VEGF gene within the retroviral vector and under the control of a tetracycline-regulated promoter, we were able to manipulate VEGF expression in vivo tumor by providing tetracycline in the drinking water.	Tetracycline	84-96	vascular endothelial growth factor A	Mus musculus	144-148	
9828211-6	1998	By delivering the VEGF gene within the retroviral vector and under the control of a tetracycline-regulated promoter, we were able to manipulate VEGF expression in vivo tumor by providing tetracycline in the drinking water.	Tetracycline	187-199	vascular endothelial growth factor A	Mus musculus	18-22	
9828211-6	1998	By delivering the VEGF gene within the retroviral vector and under the control of a tetracycline-regulated promoter, we were able to manipulate VEGF expression in vivo tumor by providing tetracycline in the drinking water.	Tetracycline	187-199	vascular endothelial growth factor A	Mus musculus	144-148	
21696760-4	2012	MATERIALS AND METHODS: We generated triple transgenic mice that express the soluble VEGF receptor, (sFlt-1), specifically in the mesenchyme (dermo-1(Cre)- tetracycline reverse transcriptional activator (rtTA)(flox/flox)-tet(0)-sflt-1).	Tetracycline	155-167	vascular endothelial growth factor A	Mus musculus	84-88	
17176614-0	2006	Tetracycline-regulated expression of VEGF-A in beta cells induces angiogenesis: improvement of engraftment following transplantation.	Tetracycline	0-12	vascular endothelial growth factor A	Mus musculus	37-43	
17176614-6	2006	VEGF secretion was increased in TET and PGK cells, and VEGF delivery resulted in angiogenesis, whereas addition of TC inhibited these processes.	Tetracycline	115-117	vascular endothelial growth factor A	Mus musculus	0-4	
12012003-5	2002	This system allows VEGF gene expression to be manipulated in vivo by providing tetracycline in the drinking water.	Tetracycline	79-91	vascular endothelial growth factor A	Mus musculus	19-23